Evaluating Adoptive Cellular Immunotherapy for Neurodegeneration with Autologous SNK01
Time: 2:30 pm
day: Translational Track Day 2 PM
Details:
- Enhancing natural killer cells to maximize the body’s ability to destroy diseased and abnormal cells
- Reviewing NK cell therapy as an alternative modality of treatment to resolve neurodegeneration with the body’s natural immune system
- Exploring phase 1 clinical safety and efficacy data of autologous SNK01 in treating neurodegenerative disease
